These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16782557)

  • 1. Catalytic autoantibodies in clinical autoimmunity and modern medicine.
    Gabibov AG; Ponomarenko NA; Tretyak EB; Paltsev MA; Suchkov SV
    Autoimmun Rev; 2006 May; 5(5):324-30. PubMed ID: 16782557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Catalytic autoantibodies in autoimmune myocarditis: clinical and pathogenetic implications].
    Kalinina EV; Ponomarenko NA; Durova OM; Paleev FN; Vorob'ev II; Kekenadze NN; Shogenov ZS; Zemtsova ME; Gnuchev NV; Gabibov AG
    Ter Arkh; 2005; 77(9):65-70. PubMed ID: 16281493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis].
    Vlasov AV; Baranovskiĭ AG; Kanyshkova TG; Prints AV; Zabara VG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinskiĭ GA
    Mol Biol (Mosk); 1998; 32(3):559-69. PubMed ID: 9720080
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenomenon of DNA-abzyme cross-reactivity and its significance for the mechanisms of cytotoxicity and apoptosis].
    Suchkov SV; Gabibov AG; Gnuchev NV
    Ontogenez; 2001; 32(5):348-52. PubMed ID: 11605407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of catalytically active antibodies with oligoribonucleotides].
    Buneva VN; Andrievskaia OA; Romannikova IV; Gololobov GV; Iadav RP; Iamkovoĭ VI; Nevinskiĭ GA
    Mol Biol (Mosk); 1994; 28(4):738-43. PubMed ID: 7990801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice.
    Silverstein A; Dudaev A; Studneva M; Aitken J; Blokh S; Miller AD; Tanasova S; Rose N; Ryals J; Borchers C; Nordstrom A; Moiseyakh M; Herrera AS; Skomorohov N; Marshall T; Wu A; Cheng RH; Syzko K; Cotter PD; Podzyuban M; Thilly W; Smith PD; Barach P; Bouri K; Schoenfeld Y; Matsuura E; Medvedeva V; Shmulevich I; Cheng L; Seegers P; Khotskaya Y; Flaherty K; Dooley S; Sorenson EJ; Ross M; Suchkov S
    Prog Mol Biol Transl Sci; 2022; 190(1):219-276. PubMed ID: 36008000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance?
    Kozyr AV; Gabibov AG
    Autoimmunity; 2009 May; 42(4):359-61. PubMed ID: 19811301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies in clinical and experimental pathology: human and mouse models.
    Ponomarenko NA; Durova OM; Vorobiev II; Aleksandrova ES; Telegin GB; Chamborant OG; Sidorik LL; Suchkov SV; Alekberova ZS; Gnuchev NV; Gabibov AG
    J Immunol Methods; 2002 Nov; 269(1-2):197-211. PubMed ID: 12379362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance].
    Khitrov AN; Romadanova NB; Ogneva EA; Naumova TE; Alekberova ZS; Vorob'ev II; Gabibov AG; Ponomarenko NA; Suchkov SV
    Ter Arkh; 2005; 77(11):75-80. PubMed ID: 16404867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiopathology of natural auto-antibodies: the case for regulation.
    Zelenay S; Moraes Fontes MF; Fesel C; Demengeot J; Coutinho A
    J Autoimmun; 2007 Dec; 29(4):229-35. PubMed ID: 17967665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between EAE development in mice and the production of autoantibodies and abzymes after immunization of mice with different antigens.
    Aulova KS; Urusov AA; Sedykh SE; Toporkova LB; Lopatnikova JA; Buneva VN; Sennikov SV; Budde T; Meuth SG; Popova NA; Orlovskaya IA; Nevinsky GA
    J Cell Mol Med; 2021 Mar; 25(5):2493-2504. PubMed ID: 33560578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological autoimmunity].
    Ternynck T; Druet P; Avrameas S
    Rev Prat; 1994 Jan; 44(1):36-8. PubMed ID: 8178056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural catalytic antibodies (abzymes) in normalcy and pathology.
    Nevinsky GA; Kanyshkova TG; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1245-55. PubMed ID: 11112840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in celiac disease.
    Alaedini A; Green PH
    Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of autoimmunity.
    Atassi MZ; Casali P
    Autoimmunity; 2008 Mar; 41(2):123-32. PubMed ID: 18324481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies with enzymatic properties in human autoimmune diseases.
    Wootla B; Lacroix-Desmazes S; Warrington AE; Bieber AJ; Kaveri SV; Rodriguez M
    J Autoimmun; 2011 Sep; 37(2):144-50. PubMed ID: 21624820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamentals of clinical immunotoxicology.
    House RV
    Methods Mol Biol; 2010; 598():363-84. PubMed ID: 19967525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in diagnostic technologies for autoimmune diseases.
    Plebani M; Pittoni M; Celadin M; Bernardi D; Mion MM
    Autoimmun Rev; 2009 Jan; 8(3):238-43. PubMed ID: 18718878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.